Anticancer Research
Anticancer Res. 2017 May;37(5):2275-2288
Genome-wide Expression Profiling (with Focus on the Galectin Network) in Tumor, Transition Zone and Normal Tissue of Head and Neck Cancer: Marked Differences Between Individual Patients and the Sites of Specimen Origin
VERONIKA ŽIVICOVÁ1,2*, PETR BROŽ3*, ZDENĚK FÍK1,2, ALŽBĚTA MIFKOVÁ1,2, JAN PLZÁK2, ZDENĚK ČADA2, HERBERT KALTNER4, JANA FIALOVÁ KUČEROVÁ3, HANS-JOACHIM GABIUS4 and KAREL SMETANA JR.1,5
1Institute of Anatomy, and 2 Department of Otorhinolaryngology, Head and Neck Surgery, First Faculty of Medicine, Charles University, Prague, Czech Republic;
3Institute of Applied Biotechnologies, Prague, Czech Republic;
4Institute of Physiological Chemistry, Faculty of Veterinary Medicine, Ludwig Maximilian University, Munich, Germany;
5BIOCEV, First Faculty of Medicine, Charles University, Vestec, Czech Republic
The color versions of Figures 3 and 4 mentioned in this article are displayed in the following links:
- Download MSR vs NOE upregulated (Excel Table, 20 kB)
- Download MSR vs NOE downregulated (Excel Table, 24 kB)
- Download MSR vs SCC upregulated (Excel Table, 16 kB)
- Download MSR vs SCC downregulated (Excel Table, 20 kB)
- Download SCC vs NOE upregulated (Excel Table, 28 kB)
- Download SCC vs NOE downregulated (Excel Table, 28 kB)
- Supplementary Figure 1
Anticancer Res. 2018 Mar;38(3):1279-1290
Detection of Distinct Changes in Gene-expression Profiles in Specimens of Tumors and Transition Zones of Tenascin-positive/-negative Head and Neck Squamous Cell Carcinoma
VERONIKA ŽIVICOVÁ1,2, PETER GÁL3,4*, ALŽBĚTA MIFKOVÁ1,2, ŠTEPÁN NOVÁK1,2, HERBERT KALTNER5, MICHAL KOLÁŘ6, HYNEK STRNAD6, JANA SÁCHOVÁ6, MILUŠE HRADILOVÁ6, MARTIN CHOVANEC7, HANS-JOACHIM GABIUS5, KAREL SMETANA JR.1,8 and ZDENĚK FÍK1,2*
1Institute of Anatomy, and 2 Department of Otorhinolaryngology, Head and Neck Surgery, First Faculty of Medicine, Charles University, Prague, Czech Republic;
3Department of Biomedical Research, East-Slovak Institute of Cardiovascular Diseases, Inc., Košice, Slovak Republic;
3Institute of Applied Biotechnologies, Prague, Czech Republic;
4Department of Pharmacology, Faculty of Medicine, Pavol Jozef Šafárik University in Košice, Košice, Slovak Republic;
5Institute of Physiological Chemistry, Faculty of Veterinary Medicine, Ludwig Maximilian University, Munich, Germany;
6Laboratory of Genomics and Bioinformatics, Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic;
7Department of Otorhinolaryngology and Head and Neck Surgery, 3rd Faculty of Medicine, University Hospital Královské Vinohrady, Charles University Prague, Prague, Czech Republic;
8BIOCEV, First Faculty of Medicine, Charles University, Vestec, Czech Republic
The following Supplementary Material mentioned in this article can be downloaded here:
- Download Supplementary Table 1 (Excel Table, 16 kB)
- Download Supplementary Table 2 (Excel Table, 24 kB)